Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Deferred Tax Liability: 2009-2016

Historic Non-Current Deferred Tax Liability for Avadel Pharmaceuticals (AVDL) over the last 2 years, with Mar 2016 value amounting to $3.5 million.

  • Avadel Pharmaceuticals' Non-Current Deferred Tax Liability fell 40.18% to $3.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was $3.5 million, marking a year-over-year decrease of 40.18%. This contributed to the annual value of $2.8 million for FY2013, which is 80.14% down from last year.
  • Avadel Pharmaceuticals' Non-Current Deferred Tax Liability amounted to $3.5 million in Q1 2016, which was down 42.23% from $6.1 million recorded in Q2 2015.
  • Avadel Pharmaceuticals' Non-Current Deferred Tax Liability's 5-year high stood at $20.9 million during Q1 2012, with a 5-year trough of $2.8 million in Q4 2013.
  • Over the past 2 years, Avadel Pharmaceuticals' median Non-Current Deferred Tax Liability value was $5.9 million (recorded in 2015), while the average stood at $5.1 million.
  • Data for Avadel Pharmaceuticals' Non-Current Deferred Tax Liability shows a maximum YoY slumped of 80.14% (in 2013) over the last 5 years.
  • Quarterly analysis of 4 years shows Avadel Pharmaceuticals' Non-Current Deferred Tax Liability stood at $14.1 million in 2012, then plummeted by 80.14% to $2.8 million in 2013, then reached $6.1 million in 2015, then tumbled by 40.18% to $3.5 million in 2016.
  • Its Non-Current Deferred Tax Liability was $3.5 million in Q1 2016, compared to $6.1 million in Q2 2015 and $5.9 million in Q1 2015.